Skip to content
Back to home

For technology and innovation

Where biosensing meets AI, new partnerships can be built.

Technology, AI, data, medical device and digital platform companies can explore joint development around a platform that turns biological signals into data.

Market opportunity

Signals only matter when they become data

Turning biosensor readings into reliable insights requires hardware, signal processing, AI and software working as one system.

  • Complex integration between devices and analytics
  • Need for robust analytical models in health
  • Growing demand for data-driven diagnostics

How DIASCI may contribute

A platform open to joint development

DIASCI combines electrochemical biosensing with an AI layer under development — a base for collaboration with specialized technology partners.

  • Analytical and AI model development
  • Hardware, data and software integrations
  • No public API, SaaS or integration is available yet

Potential applications and expected benefits

Potential areas of collaboration

Potential application

Biosensing + AI integration

Connect signal acquisition and interpretation.

Analytical models

Joint development of models for biological signals.

Future digital platforms

Possible future digital applications built on the platform.

Evidence and current stage

Technology transfer and licensing are conditioned on DIASCI's intellectual property and business strategy.

AI platform

In development.

In development

Digital products

Development hypothesis.

Development hypothesis

Intellectual property

Patent applications filed.

Patent application

DIONCO and the AI platform are in development. Preliminary, company-reported findings support further assessment; clinical and regulatory validation is still required. No product is currently approved or commercially available.

Possible collaboration models

Exploratory possibilities only. Any model depends on mutual interest, due diligence and formal agreements.

Co-development

Joint engineering of models, devices or software.

AI platform / SaaS

Possible future digital applications — not available today.

Technology transfer

Technology transfer, subject to DIASCI's strategy.

Express your interest

Discuss a technology partnership

Tell us what your company builds. We'll explore where our technologies may fit together.

What would you like to do?

An expression of interest is non-binding and does not constitute a purchase, investment or contractual obligation.